The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
ji xi ta bin lian he guo chan ka pei ta bin zhi liao wan qi san yin xing ru xian ai de lin chuang guan cha
Pages: 225-226
Year: Issue:  3
Journal: Journal of Basic and Clinical Oncology

Abstract: 目的 观察吉西他滨联合国产卡培他滨化疗方案治疗晚期三阴性乳腺癌的近期疗效和安全性.方法 采用吉西他滨联合国产卡培他滨化疗方案治疗21例既往曾接受过蒽环类、紫杉类化疗失败的晚期三阴性乳腺癌者,2周期化疗后评价近期疗效和不良反应.结果 21例患者中,CR 1例,PR 6例,SD 9例,PD 5例,有效率为33.3%.不良反应主要为Ⅰ、Ⅱ度血液学毒性、消化道反应和手足综合征等.结论 吉西他滨联合国产卡培他滨化疗方案治疗晚期三阴性乳腺癌安全有效,值得临床推广应用.
Related Articles
No related articles found